A renowned lethal interaction regards the inhibition of the BER pathway enzyme Poly (ADP-ribose) polymerase-1 (PARP-1) in ovarian and breast tumours bearing inactivating mutations in BRCA1/2 genes, which are involved in HR [71]. This evidence concerns the gene PARP1 and breast neoplasm.